SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-010953
Filing Date
2023-03-30
Accepted
2023-03-30 16:19:00
Documents
14
Period of Report
2023-03-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K grna-20230330.htm   iXBRL 8-K 56854
2 EX-99.1 grna-ex99_1.htm EX-99 18986
  Complete submission text file 0000950170-23-010953.txt   233853

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grna-20230330_pre.xml EX-101.PRE 12757
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grna-20230330.xsd EX-101.SCH 3461
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grna-20230330_lab.xml EX-101.LAB 17532
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grna-20230330_def.xml EX-101.DEF 13465
8 EXTRACTED XBRL INSTANCE DOCUMENT grna-20230330_htm.xml XML 6478
Mailing Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155
Business Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Filer) CIK: 0001822691 (see all company filings)

IRS No.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39894 | Film No.: 23780944
SIC: 2836 Biological Products, (No Diagnostic Substances)